Biogen Pharmachem Industries Ltd
BSE: 531752
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.44-23.3% | 0.58 | 0.00 | 0.00-100.0% | 1.54+14.1% | 1.35 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00-100.0% | 0.54+616.6% | -0.10 | 0.00 | 0.00-100.0% | 0.23-65.0% | 0.65 |
| Total Income | 0.44-23.3% | 0.58+6.7% | 0.54+616.6% | -0.10-106.8% | 1.54+14.1% | 1.35+493.1% | 0.23+135.0% | -0.65 |
| EXPENSES | ||||||||
| Expenditure | 0.22-76.3% | 0.94+1077.1% | 0.08-79.4% | 0.39+95.3% | 0.20+13.5% | 0.17-67.9% | 0.54+56.5% | 0.35 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| PROFIT | ||||||||
| PBT | 0.22+161.7% | -0.36-177.6% | 0.46+194.0% | -0.49-136.6% | 1.34+14.2% | 1.18+473.9% | -0.32+68.4% | -1.00 |
| Net Profit | 0.22+161.7% | -0.36-177.6% | 0.46+194.0% | -0.49-136.6% | 1.34+14.2% | 1.18+473.9% | -0.32+68.4% | -1.00 |
| KEY METRICS | ||||||||
| OPM % | 49.93%+111.98pp | -62.05% | — | — | 87.17%+0.07pp | 87.10% | — | — |
| NPM % | 49.93%+111.98pp | -62.05%-147.36pp | 85.31%-14.69pp | 100.00%+12.83pp | 87.17%+0.07pp | 87.10%+187.10pp | -100.00%-200.00pp | 100.00% |
| EPS | 0.00 | 0.00-100.0% | 0.01+0.0% | 0.01+0.0% | 0.01-50.0% | 0.02 | — | -0.02 |
Corporate Events
Board MeetingBIOGEN
202629Sep
Board Meeting
The 31st Annual General Meeting of the Members of BIOGEN PHA…
BSE Filing ↗ Board MeetingBIOGEN
20265Aug
Board Meeting
Considered and approved Un-audited financial results for the…
BSE Filing ↗ Board MeetingBIOGEN
202623Mar
Board Meeting
To consider and approve the issue of bonus shares.
BSE Filing ↗ Board MeetingBIOGEN
202425May
Board Meeting
Approve and take on record the Audited Standalone Financial …
BSE Filing ↗